Interpace Biosciences, Inc.
IDXG
$0.9077
-$0.0823-8.31%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -75.14% | -57.47% | -58.23% | -58.01% | -60.25% |
Total Receivables | 16.52% | 75.15% | 68.26% | 50.99% | 12.24% |
Inventory | -20.96% | 4.77% | -1.30% | 11.62% | 4.59% |
Prepaid Expenses | 9.45% | 2.58% | -9.32% | 0.23% | 3.89% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 58.14% | 47.37% | -8.33% | 0.00% | -92.15% |
Total Current Assets | -6.51% | 23.77% | 13.02% | -2.87% | -21.65% |
|
|||||
Total Current Assets | -6.51% | 23.77% | 13.02% | -2.87% | -21.65% |
Net Property, Plant & Equipment | 0.91% | 4.25% | 12.06% | 5.26% | 2.41% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Assets | -4.91% | 19.37% | 12.78% | -1.48% | -18.63% |
|
|||||
Total Accounts Payable | -29.02% | 27.15% | 7.45% | 25.81% | 4.26% |
Total Accrued Expenses | -69.04% | -66.84% | 10.65% | 19.15% | 14.86% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -69.34% | -59.88% | -14.68% | 1,347.58% | 265.57% |
Total Finance Division Other Current Liabilities | -11.52% | -19.76% | -32.08% | -54.82% | -48.85% |
Total Other Current Liabilities | -11.52% | -19.76% | -32.08% | -54.82% | -48.85% |
Total Current Liabilities | -62.43% | -54.26% | -7.18% | 52.30% | 40.29% |
|
|||||
Total Current Liabilities | -62.43% | -54.26% | -7.18% | 52.30% | 40.29% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -24.26% | -20.53% | -19.63% | -23.59% | -21.87% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 5.42% | 4.85% | 4.89% | 5.62% | 1.02% |
Total Liabilities | -46.79% | -43.63% | -23.10% | -17.14% | -19.45% |
|
|||||
Common Stock & APIC | 24.67% | 24.70% | 24.75% | 0.18% | 0.22% |
Retained Earnings | 4.60% | 5.66% | 2.77% | 1.89% | 1.13% |
Treasury Stock & Other | -2.22% | -2.22% | -2.29% | -2.45% | -1.96% |
Total Common Equity | 97.94% | 99.05% | 96.01% | 7.97% | 5.11% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|||||
Total Common Equity | 97.94% | 99.05% | 96.01% | 7.97% | 5.11% |
Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 90.29% | 96.02% | 75.37% | 30.96% | 20.29% |
|